A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Determine the Effect of Romiplostim on Health‐Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents

BACKGROUND: Chronic immune thrombocytopenia (ITP) in children can negatively impact their health‐related quality of life (HRQoL) and impose a burden on their parents. This study sought to examine the effect of romiplostim on HRQoL and parental burden in children with primary ITP. PROCEDURE: This was...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathias, Susan D., Li, Xiaoyan, Eisen, Melissa, Carpenter, Nancy, Crosby, Ross D., Blanchette, Victor S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071741/
https://www.ncbi.nlm.nih.gov/pubmed/27037553
http://dx.doi.org/10.1002/pbc.25984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071741/
https://www.ncbi.nlm.nih.gov/pubmed/27037553
http://dx.doi.org/10.1002/pbc.25984

Ejemplares similares